N
NPCE
Neuropace Inc
16.92
+0.64+3.93%After Hours: 16.92 0.00 0.00%16:10 05/22 EDT
OPEN/PREV CLOSE16.38/16.28
TODAY RANGE16.38-17.10
VOL172.58K
MARKET CAP576.87M
52 WEEK RANGE7.56-19.60
AVG VOL (3M)210.62K
% TURNOVER0.51%
TURNOVER--
P/E (TTM)-26.0789
% RANGE4.42%
EPS(TTM)-0.6488
P/E(FORWARD)-26.0308
P/B39.69
BVPS0.4263
DIVIDEND--
P/S5.68
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP444.51M
SHARES OUTSTANDING34.09M
NEXT EARNINGS08/10-08/14
FREE FLOAT26.27M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/15 18:24
NeuroPace price target raised to $20 from $19 at H.C. Wainwright
Dow Jones·05/15 17:45
NeuroPace Price Target Raised to $20.00/Share From $19.00 by HC Wainwright & Co.
Dow Jones·05/15 17:45
NeuroPace Is Maintained at Buy by HC Wainwright & Co.
Benzinga·05/15 17:35
HC Wainwright & Co. Maintains Buy on NeuroPace, Raises Price Target to $20
TipRanks·05/14 00:14
NeuroPace Earnings Call Highlights RNS Growth Momentum
TipRanks·05/13 13:16
NeuroPace (NPCE) Receives a Buy from Lake Street
Seeking Alpha·05/13 02:11
Neuropace signals $99M-$101M 2026 revenue outlook while targeting 21%-23% underlying RNS growth
Benzinga·05/12 21:38
NeuroPace Reports Q1 2026 Results: Full Earnings Call Transcript
TipRanks·05/12 21:03
NeuroPace reports Q1 EPS (20c), consensus (23c)
TipRanks·05/12 21:02
NeuroPace raises FY26 revenue view to $99M-$101M from $98M-$100M
Seeking Alpha·05/12 20:29
NeuroPace reports Q1 results
Reuters·05/12 20:18
NeuroPace Q1 revenue rises 20%, beats estimates, raises 2026 outlook